OasisLMS

This activity is intended for endocrinology HCPs, including physicians, physician assistants (PAs), nurse practitioners (NPs), nurses, and other HCPs interested in improving outcomes for individuals with MASLD and MASH.

Upon completion of this activity, the learner will be able to:

• Apply evidence-based recommendations for MASLD/MASH diagnosis, risk stratification, and referral to specialist care
• Employ non-invasive tests and biomarkers for optimal assessment and management of MASLD/MASH
• Implement guideline-recommended strategies for the management of MASLD/MASH, including lifestyle and weight management, early implementation of appropriate pharmacotherapy, ongoing monitoring, and collaboration with specialists where relevant
• Review evidence supporting the use of currently recommended and emerging pharmacotherapies with proven efficacy in MASH

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC)
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 1 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Endocrine Society and The Institute for Medical and Nursing Education (IMNE).

Nurses/Nurse Practitioners

IMNE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s (ANCC’s) Commission on Accreditation.

IMNE designates this educational activity for 1 contact hours of continuing education credit. Accreditation by the ANCC’s Commission on Accreditation refers to recognition of educational activities and does not imply approval or endorsement of any product.

Faculty and Disclosures

Program Chair

Kenneth Cusi, MD, FACP, FACE
Professor of Medicine Division of Endocrinology, Diabetes & Matabolism
Department of Medicine, University of Florida

Faculty


Fasiha Kanwal, MD, MSHS
Professor and Section Chief of Medicine & Gastroenterology
Baylor College of Medicine

Peer-Reviewers

Dimpi Desai, MD
Clinical Assistant Professor
Stanford University

Aman Rajpal, MD, DABOM
Clinical Assistant Professor
Alameda Health System 

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships:
Dr. Kenneth Cusi, Dr. Fashia Kanwal

The following committee members reported no relevant financial relationships:
Dr. Dimpi Desai, Dr. Aman Rajpal

The Endocrine Society staff involved in the development of this CME activity reported no relevant financial relationships.

The Institute for Medical and Nursing Education, Inc staff involed in the development of this CME activity reported no relevant financial relationships. Amy Groves, Steve Weinman, Alice Cheuk,  Michelle Fisher, Claire Barnard, Megan Widdows.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

Managed by the Endocrine Society and the Institute for Medical and Nursing Education, Inc.This educational activity is supported by an educational grant from Novo Nordisk, Inc.